Connect with us

International

Oil Price Outlook: Should investors be wary of the Goldman Kiss of Death?

Will the oil price enter a supercycle and rise exponentially this year, or will Goldman’s bullish outlook run awry? Risk remains for investors in oil stocks.
The post Oil Price Outlook: Should investors be wary of the Goldman Kiss of Death? appeared first

Published

on

Part way through the United States subprime mortgage crisis in 2008, Goldman Sachs (NYSE:GS) predicted an oil price surge that would exceed $200 a barrel. Instead, this marked the beginning of a bear cycle for the oil industry, and Goldman’s prediction became known as the kiss of death for the oil price. Today, Goldman is again airing a bullish stance on the outlook for the oil price in 2021 and beyond. But there are many dynamics at work, and investors are once more questioning this prediction.

Oil price outlook – Photographer: Robin Sommer | Source: Unsplash

A fluctuating oil price

In 2008, Goldman analyst Arjun N. Murti predicted $200 oil. He was basing this prediction on a growing addiction to oil. Plus, the belief that supply would stay tight because of geopolitical factors. Back then, famed oilman, T. Boone Pickens, was still alive and also predicting crude at $150.

Oil price chart historical
Oil price chart

The oil price did reach $169 that year, but promptly plunged to $52 by 2009. Between 2014 and 2016, it plunged again and when Covid-19 hit in 2020, an accumulation of events led to a spectacular decline that ultimately sent the oil price negative.

Since then, it has recovered to hover around the $60 a barrel range. But Goldman Sachs predicts Brent crude at $75 for Q2 of 2021, and $80 for Q3.

Oil supercycle

The push into decarbonisation is unprecedented. This is discouraging investment in the sector, which Goldman sees as creating the potential for a supply led bull run. The bullish outlook comes from forecasting an oil ‘supercycle’. To back up its stance, Goldman has identified five themes for change within the oil and gas industry.

1. Shrinking Reserves: The decarbonisation pressure from investors has ultimately stopped investment in oil and gas

2. A change in the cost curve. The shale revolution was widening the cost curve, but Covid-19 has decimated the shale industry, which means higher oil prices may be achievable once more. While some analysts see oil prices reinvigorating shale, many think the higher barriers to entry make this unlikely. And the Biden administration are clearly anti-oil.

3. The end of non-OPEC growth. Shale expansion in recent years and other non-OPEC growth, has been stopped in its tracks. But a sustained period of underinvestment will lead to fewer large oil and gas projects coming onstream.

4. Consolidation. The industry is under tremendous pressure to cut costs and put capital to work efficiently. This will inevitably lead to consolidation, cost cutting and capital efficiency.

5. Higher returns. The pressure to cut costs, will ensure capital efficiency, and capital constraints, which will lead to better returns, and better free cash flow, ultimately leading to a cycle of higher returns.

The higher barriers to entry and tighter financing conditions mean it’s the strong that are most likely to survive. The world’s strongest oil industry veterans have themselves consolidated and changed over the years.

Now, the top eight oil and gas companies are: Royal Dutch Shell(LON: RDSB), Saudi Aramco (TADAWUL: 2222), PetroChina (SHA: 601857), Sinopec (SHA: 600028), BP (NYSE: BP), Total (NYSE: TOT), Chevron (NYSE: CVX), and ExxonMobil (NYSE: XOM).

The slowdown in demand comes with a focus on climate change, which Goldman believes will lead to improved profitability.

But on the flip side it sees the oil services industry as being the most likely to suffer with companies in distress. For those to emerge victorious, they’ll need to grab long-term opportunities through consolidation, improving cost structure and transitioning into becoming energy services companies with a focus on hydrogen, carbon capture, offshore wind, and electric vehicles.

Examples of industry changes are all around us. To illustrate Bloomberg reported Arabian Drilling Co., a Saudi oilfield-services company part-owned by Schlumberger (NYSE: SLB), is preparing an initial public offering (IPO) that could give it a valuation of around $2 billion.

A short history of recent oil price volatility

When the price of oil plummeted spectacularly in April 2020, it was the accumulation of three major events.

Saudi Arabia and Russia were at war over their share of the oil market. Russia refused to slow production in an attempt to keep prices higher. But Saudi Arabia ramped up its production and heavily discounted its supply in response. This along with the worldwide slump in demand for oil caused by the Coronavirus crisis, and with US oil inventories at a record high, all led to the shock of a negative oil price on April 20.

Such a thing had never occurred before, and many didn’t know it was even possible. But the way derivatives trading works in the commodities markets meant paper traders were desperate to get rid of their futures contracts on fear of having to accept the physical oil with nowhere to store it. The shock was short lived but has left fear and uncertainty across the oil industry.

The future oil price

Today, the Brent crude oil price is around $66 and WTI crude is around $63. So, will it climb any higher from here as the world reopens?

While the UK, China and US economies appear to be attempting to reopen, many other parts of the world are still suffering badly from the pandemic. India and Brazil are in a particularly dark place, while Japan and Europe are reeling from further Covid-19 spikes. This puts more uncertainty on the pace of demand for oil resuming.

Then there’s The Organization of the Petroleum Exporting Countries (OPEC) increasing production without altering its demand forecast. It currently sees demand for the second half of 2021 reaching 5.95 million barrels per day.

Goldman remains optimistic that the aviation recovery and rising electricity demand in the Middle East, which are directly linked to crude-fired power generators, will boost oil prices throughout the year. It recently declared it expects the biggest jump in oil demand ever, thanks to successful vaccine rollouts and rising travel demand.

But consensus is not building on this outlook. A prestigious group of experts at the Oxford Institute for Energy Studies (OIES), does not see the oil price reaching $100 a barrel soon. And Saudi Energy Minister Prince Abdul Aziz bin Salman, agrees.

Bassam Fattouh and Andreas Economou of the OIES, argue:

“Some key triggers of an oil supercycle, such as an inelastic supply in the face of rampant demand and lack of spare capacity and refining constraints, which could push prices to $100 a barrel and keep them at those high levels, are still missing… Rather, oil will trade in a range of $59-$69 per barrel until the end of 2022,”

Iranian elections are another area of concern. When Trump was in power, sanctions were brought against Iran and relations soured. But if a nuclear deal is made between Tehran and Washington, there is concern Iran will be allowed to produce oil again and thus flood the market. The OIES believe this concern is overstated.

Furthermore, if the Indian Covid-19 situation continues to escalate, then oil demand from that part of the world is going to take longer to resume. And in response, the Middle East is likely to ramp up its production. This will be even more likely if Iran gets permission to produce.

The oil price has suffered extreme crashes in 1983, 1986, 1999, 2001, 2008 and 2020. After the shock of negative oil last year, it seems OPEC+ is becoming more subtle in its moves, making it harder to predict what it will do next.

As John Maynard Keynes famously said, ‘the markets can remain irrational longer than you can remain solvent’. So, where the oil price will go from here is ultimately in the lap of the gods.

The post Oil Price Outlook: Should investors be wary of the Goldman Kiss of Death? appeared first on Value the Markets.

Read More

Continue Reading

International

Analyst reviews Apple stock price target amid challenges

Here’s what could happen to Apple shares next.

Published

on

They said it was bound to happen.

It was Jan. 11, 2024 when software giant Microsoft  (MSFT)  briefly passed Apple  (AAPL)  as the most valuable company in the world.

Microsoft's stock closed 0.5% higher, giving it a market valuation of $2.859 trillion. 

It rose as much as 2% during the session and the company was briefly worth $2.903 trillion. Apple closed 0.3% lower, giving the company a market capitalization of $2.886 trillion. 

"It was inevitable that Microsoft would overtake Apple since Microsoft is growing faster and has more to benefit from the generative AI revolution," D.A. Davidson analyst Gil Luria said at the time, according to Reuters.

The two tech titans have jostled for top spot over the years and Microsoft was ahead at last check, with a market cap of $3.085 trillion, compared with Apple's value of $2.684 trillion.

Analysts noted that Apple had been dealing with weakening demand, including for the iPhone, the company’s main source of revenue. 

Demand in China, a major market, has slumped as the country's economy makes a slow recovery from the pandemic and competition from Huawei.

Sales in China of Apple's iPhone fell by 24% in the first six weeks of 2024 compared with a year earlier, according to research firm Counterpoint, as the company contended with stiff competition from a resurgent Huawei "while getting squeezed in the middle on aggressive pricing from the likes of OPPO, vivo and Xiaomi," said senior Analyst Mengmeng Zhang.

“Although the iPhone 15 is a great device, it has no significant upgrades from the previous version, so consumers feel fine holding on to the older-generation iPhones for now," he said.

A man scrolling through Netflix on an Apple iPad Pro. Photo by Phil Barker/Future Publishing via Getty Images.

Future Publishing/Getty Images

Big plans for China

Counterpoint said that the first six weeks of 2023 saw abnormally high numbers with significant unit sales being deferred from December 2022 due to production issues.

Apple is planning to open its eighth store in Shanghai – and its 47th across China – on March 21.

Related: Tech News Now: OpenAI says Musk contract 'never existed', Xiaomi's EV, and more

The company also plans to expand its research centre in Shanghai to support all of its product lines and open a new lab in southern tech hub Shenzhen later this year, according to the South China Morning Post.

Meanwhile, over in Europe, Apple announced changes to comply with the European Union's Digital Markets Act (DMA), which went into effect last week, Reuters reported on March 12.

Beginning this spring, software developers operating in Europe will be able to distribute apps to EU customers directly from their own websites instead of through the App Store.

"To reflect the DMA’s changes, users in the EU can install apps from alternative app marketplaces in iOS 17.4 and later," Apple said on its website, referring to the software platform that runs iPhones and iPads. 

"Users will be able to download an alternative marketplace app from the marketplace developer’s website," the company said.

Apple has also said it will appeal a $2 billion EU antitrust fine for thwarting competition from Spotify  (SPOT)  and other music streaming rivals via restrictions on the App Store.

The company's shares have suffered amid all this upheaval, but some analysts still see good things in Apple's future.

Bank of America Securities confirmed its positive stance on Apple, maintaining a buy rating with a steady price target of $225, according to Investing.com

The firm's analysis highlighted Apple's pricing strategy evolution since the introduction of the first iPhone in 2007, with initial prices set at $499 for the 4GB model and $599 for the 8GB model.

BofA said that Apple has consistently launched new iPhone models, including the Pro/Pro Max versions, to target the premium market. 

Analyst says Apple selloff 'overdone'

Concurrently, prices for previous models are typically reduced by about $100 with each new release. 

This strategy, coupled with installment plans from Apple and carriers, has contributed to the iPhone's installed base reaching a record 1.2 billion in 2023, the firm said.

More Tech Stocks:

Apple has effectively shifted its sales mix toward higher-value units despite experiencing slower unit sales, BofA said.

This trend is expected to persist and could help mitigate potential unit sales weaknesses, particularly in China. 

BofA also noted Apple's dominance in the high-end market, maintaining a market share of over 90% in the $1,000 and above price band for the past three years.

The firm also cited the anticipation of a multi-year iPhone cycle propelled by next-generation AI technology, robust services growth, and the potential for margin expansion.

On Monday, Evercore ISI analysts said they believed that the sell-off in the iPhone maker’s shares may be “overdone.”

The firm said that investors' growing preference for AI-focused stocks like Nvidia  (NVDA)  has led to a reallocation of funds away from Apple. 

In addition, Evercore said concerns over weakening demand in China, where Apple may be losing market share in the smartphone segment, have affected investor sentiment.

And then ongoing regulatory issues continue to have an impact on investor confidence in the world's second-biggest company.

“We think the sell-off is rather overdone, while we suspect there is strong valuation support at current levels to down 10%, there are three distinct drivers that could unlock upside on the stock from here – a) Cap allocation, b) AI inferencing, and c) Risk-off/defensive shift," the firm said in a research note.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high…

Published

on

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

Credit: IVI

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

 

The findings from this 4-year study, the Severe Typhoid in Africa (SETA) program, offers new typhoid fever burden estimates from six countries: Burkina Faso, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria, with four countries recording more than 100 cases for every 100,000 person-years of observation, which is considered a high burden. The highest incidence of typhoid was found in DRC with 315 cases per 100,000 people while children between 2-14 years of age were shown to be at highest risk across all 25 study sites.

 

There are an estimated 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths. However, with generic symptoms such as fever, fatigue, and abdominal pain, and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries.

 

“Our goal through SETA was to address these gaps in typhoid disease burden data,” said lead author Dr. Florian Marks, Deputy Director General of the International Vaccine Institute (IVI). “Our estimates indicate that introduction of TCV in endemic settings would go to lengths in protecting communities, especially school-aged children, against this potentially deadly—but preventable—disease.”

 

In addition to disease incidence, this study also showed that the emergence of antimicrobial resistance (AMR) in Salmonella Typhi, the bacteria that causes typhoid fever, has led to more reliance beyond the traditional first line of antibiotic treatment. If left untreated, severe cases of the disease can lead to intestinal perforation and even death. This suggests that prevention through vaccination may play a critical role in not only protecting against typhoid fever but reducing the spread of drug-resistant strains of the bacteria.

 

There are two TCVs prequalified by the World Health Organization (WHO) and available through Gavi, the Vaccine Alliance. In February 2024, IVI and SK bioscience announced that a third TCV, SKYTyphoid™, also achieved WHO PQ, paving the way for public procurement and increasing the global supply.

 

Alongside the SETA disease burden study, IVI has been working with colleagues in three African countries to show the real-world impact of TCV vaccination. These studies include a cluster-randomized trial in Agogo, Ghana and two effectiveness studies following mass vaccination in Kisantu, DRC and Imerintsiatosika, Madagascar.

 

Dr. Birkneh Tilahun Tadesse, Associate Director General at IVI and Head of the Real-World Evidence Department, explains, “Through these vaccine effectiveness studies, we aim to show the full public health value of TCV in settings that are directly impacted by a high burden of typhoid fever.” He adds, “Our final objective of course is to eliminate typhoid or to at least reduce the burden to low incidence levels, and that’s what we are attempting in Fiji with an island-wide vaccination campaign.”

 

As more countries in typhoid endemic countries, namely in sub-Saharan Africa and South Asia, consider TCV in national immunization programs, these data will help inform evidence-based policy decisions around typhoid prevention and control.

 

###

 

About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO) and developed a new-generation typhoid conjugate vaccine that is recently pre-qualified by WHO.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int


Read More

Continue Reading

International

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

Earlier today, CNBC’s…

Published

on

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever... And Debt Explodes

Earlier today, CNBC's Brian Sullivan took a horse dose of Red Pills when, about six months after our readers, he learned that the US is issuing $1 trillion in debt every 100 days, which prompted him to rage tweet, (or rageX, not sure what the proper term is here) the following:

We’ve added 60% to national debt since 2018. Germany - a country with major economic woes - added ‘just’ 32%.   

Maybe it will never matter.   Maybe MMT is real.   Maybe we just cancel or inflate it out. Maybe career real estate borrowers or career politicians aren’t the answer.

I have no idea.  Only time will tell.   But it’s going to be fascinating to watch it play out.

He is right: it will be fascinating, and the latest budget deficit data simply confirmed that the day of reckoning will come very soon, certainly sooner than the two years that One River's Eric Peters predicted this weekend for the coming "US debt sustainability crisis."

According to the US Treasury, in February, the US collected $271 billion in various tax receipts, and spent $567 billion, more than double what it collected.

The two charts below show the divergence in US tax receipts which have flatlined (on a trailing 6M basis) since the covid pandemic in 2020 (with occasional stimmy-driven surges)...

... and spending which is about 50% higher compared to where it was in 2020.

The end result is that in February, the budget deficit rose to $296.3 billion, up 12.9% from a year prior, and the second highest February deficit on record.

And the punchline: on a cumulative basis, the budget deficit in fiscal 2024 which began on October 1, 2023 is now $828 billion, the second largest cumulative deficit through February on record, surpassed only by the peak covid year of 2021.

But wait there's more: because in a world where the US is spending more than twice what it is collecting, the endgame is clear: debt collapse, and while it won't be tomorrow, or the week after, it is coming... and it's also why the US is now selling $1 trillion in debt every 100 days just to keep operating (and absorbing all those millions of illegal immigrants who will keep voting democrat to preserve the socialist system of the US, so beloved by the Soros clan).

And it gets even worse, because we are now in the ponzi finance stage of the Minsky cycle, with total interest on the debt annualizing well above $1 trillion, and rising every day

... having already surpassed total US defense spending and soon to surpass total health spending and, finally all social security spending, the largest spending category of all, which means that US debt will now rise exponentially higher until the inevitable moment when the US dollar loses its reserve status and it all comes crashing down.

We conclude with another observation by CNBC's Brian Sullivan, who quotes an email by a DC strategist...

.. which lays out the proposed Biden budget as follows:

The budget deficit will growth another $16 TRILLION over next 10 years. Thats *with* the proposed massive tax hikes.

Without them the deficit will grow $19 trillion.

That's why you will hear the "deficit is being reduced by $3 trillion" over the decade.

No family budget or business could exist with this kind of math.

Of course, in the long run, neither can the US... and since neither party will ever cut the spending which everyone by now is so addicted to, the best anyone can do is start planning for the endgame.

Tyler Durden Tue, 03/12/2024 - 18:40

Read More

Continue Reading

Trending